Imidazoles for the treatment of age-related cognitive disorders and alzheimer

PCT No. PCT/FI91/00172 Sec. 371 Date Nov. 30, 1992 Sec. 102(e) Date Nov. 30, 1992 PCT Filed May 30, 1991 PCT Pub. No. WO91/18886 PCT Pub. Date Dec. 12, 1991.This invention relates to the use of a compound of formula wherein X is -CH2- or can be substituted of unsubstituted; R2 is H, C1-4-alkyl, C1-4...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	MACDONALD, EWEN, LAMMINTAUSTA, RISTO A. S, VIRTANEN, RAIMO E, MIETTINEN, RIITTA A, NIEMINEN, SAKARI A, RIEKKINEN, JR., PAAVO, AIRAKSINEN, MAUNO M, VALJAKKA, ANTTI, SIRVIOE, JOUNI S. I, RIEKKINEN, PAAVO J
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	PCT No. PCT/FI91/00172 Sec. 371 Date Nov. 30, 1992 Sec. 102(e) Date Nov. 30, 1992 PCT Filed May 30, 1991 PCT Pub. No. WO91/18886 PCT Pub. Date Dec. 12, 1991.This invention relates to the use of a compound of formula wherein X is -CH2- or can be substituted of unsubstituted; R2 is H, C1-4-alkyl, C1-4-alkenyl, OH, or C1-3-alkoxy; R3 is H, CH3, C2CH3, OCH3, or Hal; R4 H, CH3, C2CH3, OCH3, or Hal, and Hal is halogen, provided that when R2 is OH or C1-3-alkoxy then X cannot be CO or a non-toxic pharmaceutically acceptable salt thereof for the use in the treatment of age related memory impairment or cognitive disorders, particularly Alzheimer's Disease.